Austar Lifesciences Ltd Shs Reg S AULSF
Trading Information
- Previous Close Price
- $0.07
- Day Range
- $0.02–0.02
- 52-Week Range
- $0.02–0.02
- Bid/Ask
- $0.00 / $1.30
- Shares Outstanding
- 512.58M
- Market Cap
- $10.25M
- Volume/Avg
- 2,000 / 2,000
Key Statistics
- Price/Earnings (Normalized)
- 3.50
- Price/Sales
- 0.04
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Austar Lifesciences Ltd is an investment holding company, and its subsidiaries are principally engaged in providing integrated engineering solutions to pharmaceutical manufacturers and research institutes, as well as manufacturing and distribution of pharmaceutical equipment and consumables in the PRC. Its products include Clean Utility Equipment & Chemical Pharmaceutical Preparation System and others. It has three business segment groups: Integrated Process and Packaging Equipment & Systems (IPS), which generates maximum revenue and combines the original business segments of Liquid and Bioprocess System and Powder and Solid System; Consulting, Digitalization, and Construction; and Life Science Equipment and Consumables. The Group generates maximum revenue from Mainland China.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,490
- Website
- https://www.austar.com.hk
Valuation
|
Metric
|
AULSF
|
|---|---|
Price/Earnings (Normalized) | 3.50 |
Price/Book Value | 0.08 |
Price/Sales | 0.04 |
Price/Cash Flow | 0.42 |
Price/Earnings
AULSF
Financial Strength
|
Metric
|
AULSF
|
|---|---|
Quick Ratio | 1.02 |
Current Ratio | 1.36 |
Interest Coverage | 4.36 |
Quick Ratio
AULSF
Profitability
|
Metric
|
AULSF
|
|---|---|
Return on Assets (Normalized) | 0.68% |
Return on Equity (Normalized) | 1.74% |
Return on Invested Capital (Normalized) | 2.03% |
Return on Assets
AULSF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|fvdh@%f | LOCK|zKM#& | $172B | |||
| Medtronic PLC
MDT
| LOCK|^SFMk# | LOCK|FJ>!x | $113B | |||
| Stryker Corp
SYK
| LOCK|bYLT>vn | LOCK|vd^ | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|^>?Jy@ | LOCK|^<hL | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|>&RTSRwx | LOCK|YnCxB | $49B | |||
| DexCom Inc
DXCM
| LOCK|m?!?mSJ | LOCK|!z>^x | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|%y<ZK^ | LOCK|kt | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|FVz | LOCK|mq$ | $24B | |||
| Steris PLC
STE
| LOCK|R&G?Wd | LOCK|$bB<P | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|k?j^>nJ | LOCK|Ww | $17B |
United States